The Recall Desk
Agency classClass IIOur severity:ModerateFDA (Devices)·Z-2319-2012·Announced 2012-09-12

Becton Dickinson Recalls BD GeneOhm Cdiff Assay Due to Tube Leakage

Becton Dickinson & Co. is recalling 32 kits of the BD GeneOhm Cdiff Assay because reaction tubes may leak. The product is distributed nationwide.

The agency’s classification

FDA (Devices): Class II

Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 2/5 (Moderate).

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class II, but the source text does not report any hospitalizations or injuries, fitting the criteria for a moderate severity voluntary precautionary recall.

Plain-English summary

Becton Dickinson & Co. is recalling 32 kits of the BD GeneOhm Cdiff Assay, Catalog # 441401. The recall is due to leakage in Cepheid SmartCycler reaction tubes. The affected lot is 08T11250 with an expiration date of 2012-07-06.

The BD GeneOhm Cdiff Assay is a qualitative in vitro diagnostic test used to detect the C. difficile toxin gene in human stool specimens. It is intended to aid in the diagnosis of Clostridium difficile-associated disease (CDAD). The product was distributed nationwide to states including California, Delaware, Florida, Georgia, Illinois, Indiana, Kansas, Kentucky, Maine, Montana, North Carolina, New Jersey, New Mexico, New York, Ohio, Oklahoma, Pennsylvania, South Carolina, Texas, Virginia, Washington, Wisconsin, and West Virginia.

Healthcare facilities and consumers should stop using the affected product and contact Becton Dickinson & Co. for further instructions or a replacement.

The recalled product

Product
BD GeneOhm Cdiff Assay , Catalog # 441401, 200 box tests 2-3 labeled in part***GeneOhm Sciences Canada, Inc., 2555 boul, du Parc-Technologique, Quebec, QC, Canada G1P 4S5*** BD GeneOhm Cdiff Assay is a qualitative in vitro diagnostic test for the direct detection of C.…
Hazard
Affected units
32

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • Lot/ Exp. 08T11250 2012-07-06

Distribution

Distributed nationwide across the United States.

The notice also names 23 states specifically:

Part of a larger recall action

This product is one of 5 recalled by Becton Dickinson & Co. under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 5 products in this recall →

Similar recalls